| NASDAQ (usa) |
|
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
| DAX (german) |
|
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Cocrystal Pharma Inc (NASDAQ: COCP)
COCP Technical Analysis
4
| As on 2nd Apr 2026 COCP STOCK Price closed @ 1.51 and we RECOMMEND Sell for LONG-TERM with Stoploss of 1.62 & Strong Sell for SHORT-TERM with Stoploss of 2.09 we also expect STOCK to react on Following IMPORTANT LEVELS. |
COCPSTOCK Price
| Open | 1.71 | Change | Price | % |
| High | 2.03 | 1 Day | 0.49 | 48.04 |
| Low | 1.36 | 1 Week | 0.45 | 42.45 |
| Close | 1.51 | 1 Month | 0.53 | 54.08 |
| Volume | 136520603 | 1 Year | -0.56 | -27.05 |
| 52 Week High 3.25 | 52 Week Low 0.86 | ||||
NASDAQ USA Most Active Stocks
| LPTX | 2.05 | 365.91% |
| AMRS | 0.14 | 100.00% |
| WBA | 11.98 | 0.50% |
| NVDA | 177.39 | 0.93% |
| COCP | 1.51 | 48.04% |
| LMDX | 0.02 | 0.00% |
| INTC | 50.38 | 4.89% |
| YGMZ | 0.02 | -66.67% |
| PLUG | 2.41 | 7.11% |
| TIRX | 0.03 | -50.00% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| COCP Daily Charts |
COCP Intraday Charts |
Whats New @ Bazaartrend |
COCP Free Analysis |
|
|
COCP Important Levels Intraday
| RESISTANCE | 2.80 |
| RESISTANCE | 2.39 |
| RESISTANCE | 2.13 |
| RESISTANCE | 1.88 |
| SUPPORT | 1.14 |
| SUPPORT | 0.89 |
| SUPPORT | 0.63 |
| SUPPORT | 0.22 |
COCP Forecast April 2026
| 4th UP Forecast | 4.3 |
| 3rd UP Forecast | 3.41 |
| 2nd UP Forecast | 2.85 |
| 1st UP Forecast | 2.3 |
| 1st DOWN Forecast | 0.72 |
| 2nd DOWN Forecast | 0.17 |
| 3rd DOWN Forecast | -0.39 |
| 4th DOWN Forecast | -1.28 |
COCP Weekly Forecast
| 4th UP Forecast | 2.17 |
| 3rd UP Forecast | 1.96 |
| 2nd UP Forecast | 1.83 |
| 1st UP Forecast | 1.70 |
| 1st DOWN Forecast | 1.32 |
| 2nd DOWN Forecast | 1.19 |
| 3rd DOWN Forecast | 1.06 |
| 4th DOWN Forecast | 0.85 |
COCP Forecast2026
| 4th UP Forecast | 6.13 |
| 3rd UP Forecast | 4.65 |
| 2nd UP Forecast | 3.73 |
| 1st UP Forecast | 2.82 |
| 1st DOWN Forecast | 0.2 |
| 2nd DOWN Forecast | -0.71 |
| 3rd DOWN Forecast | -1.63 |
| 4th DOWN Forecast | -3.11 |
Cocrystal Pharma Inc ( NASDAQ USA Symbol : COCP )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
COCP Other Details
| Segment | EQ | |
| Market Capital | 87419768.00 | |
| Sector | Healthcare | |
| Industry | Biotechnology | |
| Offical website | > echo $website ; ?> | |
COCP Address
![]() |
||
COCP Latest News
COCP Business Profile
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company develops CC-31244, a HCV non-nucleoside polymerase inhibitor that has completed Phase 2a clinical trial to treat HCV infection; and CC-42344, a PB2 inhibitor that is in preclinical development trials for treating influenza infection. It is also involved in identifying and developing non-nucleoside polymerase inhibitors for norovirus infections. Cocrystal Pharma, Inc. has a license and research collaboration agreement with Merck Sharp & Dohme Corp. to discover and develop proprietary influenza A/B antiviral agents; a license agreement with Kansas State University Research Foundation to develop antiviral compounds for the treatment of norovirus and coronavirus infections; and drug discovery collaboration with HitGen and InterX Inc. The company is headquartered in Bothell, Washington. Address: 19805 North Creek Parkway, Bothell, WA, United States, 98011
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service

